Company Filing History:
Years Active: 2006
Title: Klemens Kaupmann: Innovator in GABAreceptor Research
Introduction
Klemens Kaupmann is a notable inventor based in Lörrach, Germany. He has made significant contributions to the field of neuroscience through his innovative research and patents. His work primarily focuses on GABAreceptors, which play a crucial role in the central and peripheral nervous systems.
Latest Patents
Kaupmann holds a patent that provides purified GABAreceptors and receptor proteins derived from rat and human sources. The patent also includes nucleic acids that encode such proteins. The proteins and nucleic acids share significant homology with the GABAreceptor and the DNA encoding it. Furthermore, the invention outlines methods for isolating other members of the GABAreceptor family using DNA cloning technology and probes derived from the sequences provided. This patent is instrumental in identifying and characterizing compounds that modulate the activity of GABAreceptors, which may be useful as pharmacological agents for treating various disorders.
Career Highlights
Kaupmann is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to contribute to groundbreaking research in the field of pharmacology and neuroscience. His innovative approaches have paved the way for new treatments and therapies.
Collaborations
Kaupmann has collaborated with esteemed colleagues such as Bernhard Bettler and Helmut Bittiger. These collaborations have further enhanced the impact of his research and innovations in the scientific community.
Conclusion
Klemens Kaupmann is a distinguished inventor whose work on GABAreceptors has significant implications for neuroscience and pharmacology. His contributions continue to influence the development of new therapeutic agents.